NERM
ELAN icon

New England Research & Management’s Elanco Animal Health ELAN Stock Holding History

New England Research & Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,400
Closed -$518K – 168
2022
Q2 		$518K Sell
26,400
-750
-3% -$17.8K 0.3% 107
2022
Q1 		$708K Buy
27,150
+2,600
+11% +$69.2K 0.37% 86
2021
Q4 		$697K Buy
24,550
+9,550
+64% +$297K 0.34% 89
2021
Q3 		$478K Buy
15,000
+1,150
+8% +$38.6K 0.25% 111
2021
Q2 		$480K Sell
13,850
-1,700
-11% -$56.1K 0.25% 118
2021
Q1 		$458K Sell
15,550
-550
-3% -$16.9K 0.25% 110
2020
Q4 		$494K Sell
16,100
-4,500
-22% -$137K 0.31% 100
2020
Q3 		$575K Sell
20,600
-11,600
-36% -$294K 0.42% 84
2020
Q2 		$691K Sell
32,200
-5,800
-15% -$128K 0.49% 76
2020
Q1 		$851K Buy
38,000
+2,900
+8% +$79.4K 0.73% 46
2019
Q4 		$1.03M Buy
35,100
+3,500
+11% +$95.1K 0.69% 51
2019
Q3 		$840K Buy
31,600
+22,100
+233% +$663K 0.61% 58
2019
Q2 		$321K Buy
+9,500
New +$308K 0.22% 132

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

New England Research & Management's ELAN Position: Q3 2022 in Review

New England Research & Management sold out of Elanco Animal Health (ELAN) in Q3 2022, closing a stake of 26,400 shares — an estimated $518K sold.

New England Research & Management first reported a position in ELAN in Q2 2019 and held it in 13 quarters. The position peaked at $1.03M in Q4 2019. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

  • New England Research & Management reported no remaining Elanco Animal Health position as of Q3 2022 after selling out during the quarter.
  • New England Research & Management sold 26,400 Elanco Animal Health shares in Q3 2022, an estimated $518K.
  • New England Research & Management first reported a position in Elanco Animal Health in Q2 2019 and held it in 13 quarters.
  • New England Research & Management's Elanco Animal Health position peaked at $1.03M in Q4 2019.
  • 419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on New England Research & Management's 13F filing for Q3 2022, filed 6 Oct 2022.